JP3579617B2 - Nutritional composition with good emulsion stability - Google Patents

Nutritional composition with good emulsion stability Download PDF

Info

Publication number
JP3579617B2
JP3579617B2 JP23140399A JP23140399A JP3579617B2 JP 3579617 B2 JP3579617 B2 JP 3579617B2 JP 23140399 A JP23140399 A JP 23140399A JP 23140399 A JP23140399 A JP 23140399A JP 3579617 B2 JP3579617 B2 JP 3579617B2
Authority
JP
Japan
Prior art keywords
hydrolyzate
whey protein
nutritional composition
manufactured
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP23140399A
Other languages
Japanese (ja)
Other versions
JP2001054367A (en
Inventor
宏紀 早澤
吉隆 田村
博 宮川
善太 高津
光徳 高瀬
陽子 赤染
洋 岩本
禎一郎 大川
俊和 七野
重文 北川
彦克 金原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Priority to JP23140399A priority Critical patent/JP3579617B2/en
Publication of JP2001054367A publication Critical patent/JP2001054367A/en
Application granted granted Critical
Publication of JP3579617B2 publication Critical patent/JP3579617B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • General Preparation And Processing Of Foods (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Grain Derivatives (AREA)

Description

【0001】
【発明の属する技術分野】
本発明は、乳化安定性の良好な流動食、育児用ミルク等の栄養組成物に関する。詳しくは、本発明は、脂肪、乳清蛋白加水分解物、カゼイン加水分解物、及び乳化剤としてコハク酸モノグリセリド及び/又はタピオカ澱粉を含有することを特徴とする乳化安定性の良好な栄養組成物に関する。
【0002】
尚、本明細書において、百分率(%)の表示は、特に断りのない限り重量による値である。
【0003】
【従来の技術】
従来、乳化剤として(i) クエン酸モノグリセリド又はコハク酸モノグリセリド、(ii)脂肪酸モノグリセリド、及び(iii) 酵素処理レシチンの3種の乳化剤を併用することにより、乳化安定性が向上した脂肪、蛋白加水分解物等からなる栄養組成物(特許第2824598号公報。以下、従来技術1と記載する。)、乳化剤及び乳化安定剤として、HLBが10未満のモノグリセリド有機酸エステル、及びHLBが10以上の耐酸耐塩性の界面活性剤、又はこれらと耐塩性の高分子化合物を併用することにより、乳化安定性が向上した脂肪、蛋白加水分解物等からなる液状栄養組成物(特開平9−157179号公報。以下、従来技術2と記載する。)等が知られている。
【0004】
また、タピオカ澱粉及びアルギン酸プロピレングリコールエステル(以下、PGAと記載する。)を併用することにより、乳化安定性が向上した脂肪等からなる蛋白加水分解物を含有しない安定な乳化食品(特開昭47−23575号公報。以下、従来技術3と記載する。)が知られている。
【0005】
しかしながら、これらの従来技術には、次に記載するとおりの不都合があった。
【0006】
【発明が解決しようとする課題】
前記従来の技術に開示されているとおり、コハク酸モノグリセリドを他の乳化剤と併用することにより、乳化安定性が向上した脂肪、蛋白加水分解物等からなる栄養組成物が開発されていた。しかしながら、前記従来技術の乳化剤の組合せにおいては、蛋白加水分解物として乳清蛋白加水分解物及びカゼイン加水分解物を使用した場合には、栄養組成物の乳化安定性が不十分であるという問題点があった。
【0007】
即ち、前記従来技術1のコハク酸モノグリセリド、脂肪酸モノグリセリド、及び酵素処理レシチンの3種の乳化剤を併用した場合には、後記する試験例からも明らかなとおり、脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物等からなる栄養組成物の乳化安定性が不十分であるという問題点があった。
【0008】
また、前記従来技術2のHLBが10未満のモノグリセリド有機酸エステルとしてコハク酸モノグリセリド、HLBが10以上の耐酸耐塩性の界面活性剤としてヘキサグリセリンモノミリステート等のポリグリセリン脂肪酸エステル、並びに耐塩性の高分子化合物としてヒドロキシエチルセルロース及びヒドロキシプロピルセルロースを併用した場合には、後記試験例からも明らかなとおり、脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物等からなる栄養組成物の乳化安定性が不十分であるという問題点があった。
【0009】
更に、前記従来技術3に開示されているとおり、タピオカ澱粉及びPGAを併用することにより、乳化安定性が向上した脂肪等からなる蛋白加水分解物を含有しない安定な乳化食品が開発されていた。しかしながら、蛋白加水分解物を含有する乳化食品にタピオカ澱粉及びPGAを併用した場合には、栄養組成物の乳化安定性が不十分であるという問題点があった。
【0010】
即ち、前記従来技術3のタピオカ澱粉及びPGAを併用した場合には、後記する試験例からも明らかなとおり、脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物等からなる栄養組成物の乳化安定性が不十分であるという問題点があった。
【0011】
本発明者らは、前記従来技術に鑑みて、脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物等からなる栄養組成物の乳化安定性の向上を目的とし、後記する試験例に一部示されるとおり、種々の乳化剤及びその組み合わせについて試験した。
【0012】
その結果、本発明者らは、従来技術に開示される乳化剤を併用使用する場合に比較して、乳化剤としてコハク酸モノグリセリド及び/又はタピオカ澱粉を使用した場合に、脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物等からなる栄養組成物の乳化安定性の向上に優れていることを見出し、本発明を完成した。
【0013】
本発明の目的は、母乳の蛋白質組成に近似しており、アレルゲン性が低減され、乳幼児の保育に有用な育児用ミルク等に応用可能な脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物を主要な成分とする新規で乳化安定性の良好な栄養組成物を提供することである。
【0014】
【課題を解決するための手段】
前記課題を解決する本発明は、脂肪、乳清蛋白加水分解物及びカゼイン加水分解物を主要な成分とする乳化安定性の良好な栄養組成物であって、脂肪、乳清蛋白加水分解物及びカゼイン加水分解物のみからなる蛋白質源、及び乳化剤としてコハク酸モノグリセリド及び/又はタピオカ澱粉を含有することを特徴とする乳化安定性の良好な育児用ミルクである。
【0015】
また、本発明は、乳清蛋白加水分解物が、蛋白質含量が少なくとも70%の乳清蛋白質の加水分解物であって、次のa)〜h)、
a)分子量5000〜10000ダルトンの画分が、全加水分解物の1%未満であること
b)抗乳清蛋白質血清を用いたエライザ抑制試験法により測定した抗原残存活性が10-5以下であること
c)加水分解物の全アミノ酸の量に対する遊離アミノ酸の量の割合が10〜15%であること
d)乳清蛋白質に含まれる全リジンの量に対する遊離リジンの量の割合が12〜20%であること
e)アンモニア含量が0.2%以下であること
f)10%溶液を1cmのセル、540nmで測定した透過率が98%以上であること、g)pH4〜7の5%溶液を120℃で10分間加熱して沈澱を生じないこと、
h)抗酸化活性を有すること
の理化学的性質を有する風味良好な乳清蛋白加水分解物であることを特徴とする上記乳化安定性の良好な育児用ミルク(以下、態様1と記載する。)を望ましい態様としてもいる。
【0016】
【発明の実施の形態】
次に、本発明について詳細に説明する。
【0017】
本発明に使用する脂肪は、食品又は医薬品に許容されるものであれば如何なる脂肪であってもよく、具体的には、大豆油、とうもろこし油、ナタネ油、ココヤシ油、サフラワー油、ヒマワリ油、オリーブ油等の植物性油脂、ラード、牛脂、乳脂肪、魚油等の動物性脂肪、MCT、高度不飽和脂肪酸(エイコサペンタエン酸、アラキドン酸、ドコサヘキサエン酸、γ−リノレン酸、ジホモ−γ−リノレン酸、リノール酸等)、これらの加工油等を例示することができるが、簡便には、市販の調整脂肪(例えば、太陽油脂社製等。)を使用することができる。
【0018】
本発明に使用する乳清蛋白加水分解物は、ホエー、脱塩ホエー、乳清蛋白濃縮物(WPC)、乳清蛋白分離物(WPI)等の食品又は医薬品に許容される乳清蛋白質原料を加水分解したものであれば如何なる乳清蛋白加水分解物であってもよいが、乳清蛋白加水分解物の風味及び抗原残存活性を考慮すると、本発明者らが先に出願した先願特許1(特開平8−112063号公報)の開示に従って、後記参考例1により製造される本発明の態様1に示す加水分解物が望ましい。
【0019】
即ち、蛋白質含量が少なくとも70%の乳清蛋白質の加水分解物であって、次のa)〜h)、
【0020】
a)分子量5000〜10000ダルトンの画分が、全加水分解物の1%未満であること
b)抗乳清蛋白質血清を用いたエライザ抑制試験法により測定した抗原残存活性が10−5以下であること
c)加水分解物の全アミノ酸の量に対する遊離アミノ酸の量の割合が10〜15%であること
d)乳清蛋白質に含まれる全リジンの量に対する遊離リジンの量の割合が12〜20%であること
e)アンモニア含量が0.2%以下であること
f)10%溶液を1cmのセル、540nmで測定した透過率が98%以上であること
g)pH4〜7の5%溶液を120℃で10分間加熱して沈澱を生じないこと
h)抗酸化活性を有すること
の理化学的性質(以下、特定の理化学的性質と記載する。)を有する風味良好な乳清蛋白加水分解物であることが望ましい。尚、前記特定の理化学的性質を有する風味良好な乳清蛋白加水分解物は、他の乳清蛋白加水分解物と比較して乳化安定性が悪いことから、本発明による乳化安定性の改善効果が著しく、本発明により、該乳清蛋白加水分解物を含有する乳化安定性の良好な栄養組成物の製造が可能となった。
【0021】
本発明に使用するカゼイン加水分解物は、乳酸カゼイン、塩酸カゼイン等の酸カゼイン、カゼインナトリウム、カゼインカリウム、カゼインカルシウム等のカゼイン塩等の食品又は医薬品に許容されるカゼイン蛋白質原料を加水分解したものであれば如何なるカゼイン加水分解物であってもよく、具体的には、本発明者らが先に出願した先願特許2(特開平8−228692号公報)又は先願特許3(特開平9−28306号公報)の開示に従って、後記参考例2又は参考例3により製造されるカゼイン加水分解物を使用することができる。
【0022】
本発明に使用する乳化剤は、後記試験例から明らかなとおり、食品又は医薬品に許容されるコハク酸モノグリセリド及び/又はタピオカ澱粉である必要があり、これらの市販品であるコハク酸モノグリセリド(花王社製)、タピオカ澱粉(松谷化学工業社製)等を使用することができる。乳化剤の添加量は、栄養組成物の固形分当たり、0.01〜15%である。また、一層乳化安定性を向上させるためには、コハク酸モノグリセリド又はタピオカ澱粉のいずれか一方を単独使用することが必要であり、特にコハク酸モノグリセリドの単独使用が望ましい。
【0023】
本発明の乳化安定性の良好な栄養組成物の蛋白質源としては、主要な成分である乳清蛋白加水分解物及びカゼイン加水分解物が全蛋白質の60%以上使用されるが、これら以外の蛋白質、その分解物、又はアミノ酸を使用することもできる。乳清蛋白加水分解物及びカゼイン加水分解物以外の蛋白質としては、大豆蛋白質、卵蛋白質、魚蛋白質、肉蛋白質、小麦蛋白質、とうもろこし蛋白質、ラクトフェリン、ラクトパーオキシダーゼ等の1種又は2種以上の組合せを例示することができる。
【0024】
尚、乳清蛋白加水分解物及びカゼイン加水分解物の蛋白質としての比率は、1:9乃至9:1の範囲で適宜変更可能であるが、乳幼児の哺乳に有用な育児用ミルクに応用する目的で、母乳の乳清蛋白質及びカゼイン蛋白質の比率に近似した1.5:1程度の比率とすることが望ましい。
【0025】
本発明の乳化安定性の良好な栄養組成物の主要な成分である脂肪、乳清蛋白加水分解物、カゼイン加水分解物、及び乳化剤以外の成分としては、食品又は医薬品に許容される糖質、食物繊維、核酸、ビタミン、ミネラル等が例示できる。
【0026】
糖質としては、デキストリン、ラクトース、シュークロース、グルコース、フルクトース、マルトース、ラクチュロース、ラフィノース等の1種又は2種以上の組合せを例示することができる。
【0027】
食物繊維としては、セルロース、難消化デキストリン、アラビヤガム等の1種又は2種以上の組合せを例示することができる。
【0028】
核酸としては、ヌクレオチド、ヌクレオシド、DNA、RNA、塩基等の1種又は2種以上の組合せを例示することができる。
【0029】
ビタミンとしては、ビタミンA、ビタミンB、ビタミンB 、ビタミンB 、ビタミン12、ビタミンC、ビタミンD、ビタミンE、ビタミンK、ナイアシン、パントテン酸、葉酸、β−カロチン等の1種又は2種以上の組合せを例示することができるが、簡便には、市販のビタミン混合物(例えば、田辺製薬社製等。)を使用することができる。
【0030】
また、ミネラルとしては、ナトリウム、カリウム、塩素、カルシウム、マグネシウム、鉄、銅、亜鉛、マンガン等の塩類の1種又は2種以上の組合せを例示することができるが、簡便には、市販のミネラル混合物(例えば、富田製薬社製等。)を使用することができる。
【0031】
更に、必要に応じて、果汁、フレーバー類、乳酸菌末、ビフィズス菌末等を使用することができる。
【0032】
本発明の乳化安定性の良好な栄養組成物中の全脂肪、全蛋白質、及び全糖質の配合割合は、使用目的により栄養学的観点から種々の割合で配合される。例えば、育児用ミルクの配合割合は、通常、育児用ミルクの固形分当たり、脂肪は10〜30%、蛋白質は10〜20%、糖質は50〜70%程度である。微量成分であるビタミン及びミネラルは栄養上必要な量を適宜添加される。
【0033】
本発明の栄養組成物の調製方法は、栄養組成物の種類に対応する常法によって調製することができるが、代表的な栄養組成物である育児用ミルクの場合には、次のとおり調製される。
【0034】
具体的には、前記乳清蛋白加水分解物、前記カゼイン加水分解物、前記糖質、前記ミネラル混合物、及び前記ビタミン混合物を精製水に溶解し、これに前記乳化剤及び前記脂肪を添加し、均質化し、常法により殺菌し、濃縮し、噴霧乾燥し、育児用ミルクを調製する。
【0035】
以上により得られる本発明の栄養組成物は、後記する実施例及び試験例からも明らかなとおり、脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物等からなる栄養組成物の乳化安定性が良好であることから、母乳の蛋白質組成に近似しており、アレルゲン性が低減され、乳幼児の保育に有用な育児用ミルク等に応用可能で有用である。
【0036】
次に、試験例を示して本発明を詳細に説明するが、本発明においては、次の試験方法を採用した。
【0037】
(1)乳化安定性の評価方法
試料を固形分15%の濃度で蒸留水に溶解し、この10mlを50ml容量遠沈管に分取し、2000rpmで5分間遠心分離し、上層に浮上するクリーム層の容積(ml)を測定し、乳化安定性の評価指標とした。
【0038】
試験例1
この試験は、従来技術により製造した栄養組成物と比較して本発明の栄養組成物が乳化安定性に優れていることを示すために行った。
【0039】
(1)試料の調製
次に示す5種類の試料を調製した。
試料1:本発明の実施例1と同一の方法により製造した栄養組成物
試料2:乳化剤として、本発明のタピオカ澱粉6kgを単独使用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
試料3:乳化剤として、従来技術1のコハク酸モノグリセリド450g、脂肪酸モノグリセリド450g、及び酵素処理レシチン450gを併用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
試料4:乳化剤として、従来技術2のコハク酸モノグリセリド1440g、ヘキサグリセリンモノミリステート960g、ヒドロキシエチルセルロース600g、及びヒドロキシプロピルセルロース600gを併用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
試料5:乳化剤として、従来技術3のタピオカ澱粉6kg、及びPGA440gを併用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
【0040】
(2)試験方法
各試料の乳化安定性を、前記の試験方法により各試料毎に5回測定して平均値を算出して試験した。
【0041】
(3)試験結果
この試験の結果は、表1に示すとおりである。表1から明らかなとおり、従来技術の乳化剤を使用した試料2乃至試料4に比較して本発明の試料1は、クリーム層の浮上量が少なく乳化安定性に優れていることが判明した。
【0042】
尚、栄養組成物の脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物の種類、並びに量を変更して試験したが、ほぼ同様の結果が得られた。
【0043】
【表1】

Figure 0003579617
【0044】
試験例2
この試験は、乳化安定性を指標として、脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物等からなる栄養組成物の適正な乳化剤の種類及びその組合せを調べるために行った。
【0045】
(1)試料の調製
乳化剤の種類及びその組合せを変更したことを除き、実施例1と同一の方法により次に示す11種類の試料(試料番号6〜16)を調製した。
試料6:本発明の実施例1と同一の方法により製造した栄養組成物
試料7:乳化剤として、本発明のタピオカ澱粉6kgを単独使用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
試料8:乳化剤として、本発明のコハク酸モノグリセリド450g、及びタピオカ澱粉6kgを併用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
試料9:乳化剤として、クエン酸モノグリセリド450gを単独使用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
【0046】
試料10:乳化剤として、バレイショ澱粉6kgを単独使用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
試料11:乳化剤として、クエン酸モノグリセリド450g、及びタピオカ澱粉6kgを併用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
試料12:乳化剤として、コハク酸モノグリセリド450g、及びバレイショ澱粉6kgを併用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
試料13:乳化剤として、クエン酸モノグリセリド450g、及びバレイショ澱粉6kgを併用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
試料14:乳化剤として、ステアリン酸モノグリセリド450gを単独使用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
試料15:乳化剤として、ステアリン酸モノグリセリド450g、及びタピオカ澱粉6kgを併用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
試料16:乳化剤として、ステアリン酸モノグリセリド450g、及びバレイショ澱粉6kgを併用したことを除き、本発明の実施例1と同一の方法により製造した栄養組成物
【0047】
(2)試験方法
各試料の乳化安定性を、前記の試験方法により各試料毎に5回測定して平均値を算出して試験した。
【0048】
(3)試験結果
この試験の結果は、表2に示すとおりである。表2から明らかなとおり、脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物等からなる栄養組成物の乳化安定性を向上させるためには、乳化剤としてコハク酸モノグリセリド及び/又はタピオカ澱粉を使用することが必要であることが判明した。また、一層乳化安定性を向上させるためには、コハク酸モノグリセリド又はタピオカ澱粉のいずれか一方を単独使用することが必要であり、特にコハク酸モノグリセリドの単独使用が望ましいことが判明した。
【0049】
尚、栄養組成物の脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物の種類、並びに量を変更して試験したが、ほぼ同様の結果が得られた。
【0050】
【表2】
Figure 0003579617
【0051】
参考例1
先願特許1(特開平8−112063号公報)の実施例2と同一の方法により、乳清蛋白加水分解物を次のとおり調製した。
【0052】
市販の乳清蛋白質粉末(蛋白質含量85%。デンマーク・プロテイン社製)1kgを、脱イオン水19kgに溶解し、pHを10に調整し、トリプシン(ノボ・ノルディスク社製)を11万活性単位(乳清蛋白質1g当たり130活性単位)、プロテアーゼNアマノ(天野製薬社製)180万活性単位(乳清蛋白質1g当たり2100活性単位)及びラクトバチルス・ブルガリカス菌体破砕物5.1万活性単位(乳清蛋白質1g当たり60活性単位)を添加し、40℃で加水分解し、バイオテックアナライザー(旭化成工業社製)を用いて経時的に遊離リジンの量を測定し、遊離リジン量が17%に達した時点で、130℃で2秒間加熱して酵素を失活させ、冷却し、のちクエン酸でpHを6.5に調整し、分画分子量3,000の限外瀘過膜(旭化成工業社製)で限外瀘過し、濃縮し、噴霧乾燥し、粉末状の乳清蛋白加水分解物約800gを得た。
【0053】
得られた乳清蛋白加水分解物は、分子量5,000〜10000ダルトンの画分が、全加水分解物の0.2%、抗原残存活性が10−6以下、リジンの遊離率が17%、遊離アミノ酸含量13%、アンモニア含有量が0.04%、10%溶液の透過率が99%、5%溶液のpH未調整及びpH4における120℃、10分間の加熱にも安定であり、α−トコフェロールと同等の抗酸化活性を有し、風味も良好であった。
【0054】
参考例2
先願特許2(特開平8−228692号公報)の実施例2と同一の方法により、カゼイン加水分解物を次のとおり調製した。
【0055】
市販のカゼイン(メルク社製)1.5kgに蒸留水8.5kgを加え、よく分散させ、10%水酸化ナトリウム水溶液を添加して、溶液のpHを7.0に調整し、カゼインを完全に溶解し、濃度約15%のカゼイン水溶液を調製した。該カゼイン水溶液を85℃で10分間加熱殺菌し、50℃に温度調整し、水酸化ナトリウムを添加して、pHを9.0に調整した後、ビオプラーゼSP−20(長瀬生化学工業社製)151.2万活性単位(蛋白質1g当たり1200活性単位)、ニュートラーゼ(ノボ・ノルディスク社製)630万活性単位(蛋白質1g当たり5000活性単位)、及びキモトリプシン(ノボ・ノルディスク社製)1008万活性単位(蛋白質1g当たり8000活性単位)を添加して加水分解反応を開始し、経時的にカゼインの分解率及びバイオテックアナライザー(旭化成工業社製)により測定される16種類のアミノ酸のモル数の合計の測定値をそれぞれ測定し、カゼインの分解率が25.5%及びバイオテックアナライザーによる測定値が7.2mMに達した時点で、85℃で5分間加熱して酵素を失活させ、酵素反応を停止し、10℃に冷却した。この加水分解液に活性炭60gを加え、撹拌後20時間静置し、瀘過助剤としてスタンダードスーパーセル(東京珪藻土社製)を加え、吸引瀘過し、次いで、得られた瀘過液を常法により濃縮、噴霧乾燥し、噴霧乾燥品1.32kgを得た。
【0056】
得られたカゼイン加水分解物は、分子量500ダルトン以下の画分が60.9%、500超1000ダルトン以下の画分が22.9%、1000超5000ダルトン以下の画分が16.2%、5000ダルトンを超える画分が0%、抗原残存活性が10−5、及びアミノ酸遊離率が5.9%であり、風味も良好であった。
【0057】
参考例3
先願特許3(特開平9−28306号公報)の実施例2と同一の方法により、カゼイン加水分解物を次のとおり調製した。
【0058】
市販のカゼインナトリウム(蛋白質含量85%。ユニーレ・フランス社製)1kgに蒸留水9kgを加え、よく撹拌混合し、カゼインナトリウムを完全に溶解し、濃度約10%のカゼイン水溶液を調製した。該カゼイン水溶液を80℃で10分間加熱殺菌し、50℃に温度調整し、水酸化ナトリウムを添加してpHを9.0に調整し、ブロメライン(天野製薬社製)1360万活性単位(蛋白質1g当たり16000活性単位)、ニュートラーゼ(ノボ・ノルディスク社製)177万活性単位(蛋白質1g当たり2000活性単位)、及びプロテアーゼS(天野製薬社製)102万活性単位(蛋白質1g当たり1200活性単位)を添加して加水分解反応を開始し、経時的に酵素反応を分解率によりモニターし、分解率が25.6%に達した時点で、80℃で6分間加熱して酵素を失活させ、酵素反応を停止し、10℃に冷却した。この加水分解液をマイクローザEMP−313(孔径0.25μm:旭化成社製)を用い、膜分離法(マイクロフィルトレーション)により、不溶物を瀘過し、次いで得られた瀘過液を疎水性樹脂[KS−35(北越炭素社製)]に対して、該瀘過液をSV(空間速度)=2h−1、温度10℃の条件で接触処理し、得られたカゼイン加水分解物を含有する溶液を常法により濃縮し、噴霧乾燥し、噴霧乾燥品0.74kgを得た。
【0059】
得られたカゼイン加水分解物は、分子量1000ダルトン以下の画分が82.5%、3500ダルトン以上の画分が0.2%、アミノ酸遊離率が5.3%、1g中に含まれるトリプトファンが3.5mg及び透過率が99.4%であった。また、風味(匂い、呈味)は、ほとんど無味無臭であり、保存安定性(沈澱は無く、着色も無い。)に優れた物質であった。
【0060】
次に実施例を示して本発明を更に詳細に説明するが、本発明は以下の実施例に限定されるものではない。
【0061】
【実施例】
実施例1
前記参考例1と同一の方法を反復して得られた乳清蛋白加水分解物15kg、前記参考例2と同一の方法を反復して得られたカゼイン加水分解物10kg、ラクトース(メグレ社製)68kg、ラフィノース(日本甜菜製糖社製)1120g、マルツデキストリン(松谷化学工業社製)14.6kg、ミネラル混合物(富田製薬社製)920g、及びビタミン混合物(田辺製薬社製)35gを精製水300kgに溶解し、これにコハク酸モノグリセリド(花王社製)450g及び調整脂肪(太陽油脂社製)40kgを添加し、均質化し、120℃で2秒間殺菌し、濃縮し、噴霧乾燥し、育児用ミルク約145kgを得た。
【0062】
得られた育児用ミルクを前記試験方法により試験した結果、乳化安定性が良好で、風味についても優れた栄養組成物であった。
【0063】
実施例2
前記参考例1と同一の方法を反復して得られた乳清蛋白加水分解物10.8kg、前記参考例2と同一の方法を反復して得られたカゼイン加水分解物5.6kg、ラクチュロース(森永乳業社製)500g、ラフィノース(日本甜菜製糖社製)500g、マルツデキストリン(松谷化学工業社製)65kg、ミネラル混合物(富田製薬社製)920g、及びビタミン混合物(田辺製薬社製)35gを精製水300kgに溶解し、これにコハク酸モノグリセリド(花王社製)500g及び調整脂肪(太陽油脂社製)20kgを添加し、均質化し、80℃で6分間殺菌し、濃縮し、噴霧乾燥し、育児用ミルク約100kgを得た。
【0064】
得られた育児用ミルクを前記試験方法により試験した結果、乳化安定性が良好で、風味についても優れた栄養組成物であった。
【0065】
実施例3
前記参考例1と同一の方法を反復して得られた乳清蛋白加水分解物10kg、前記参考例2と同一の方法を反復して得られたカゼイン加水分解物6kg、ラクチュロース(森永乳業社製)500g、ラフィノース(日本甜菜製糖社製)500g、マルツデキストリン(松谷化学工業社製)62kg、タピオカ澱粉(松谷化学工業社製)3kg、ミネラル混合物(富田製薬社製)920g、及びビタミン混合物(田辺製薬社製)35gを精製水300kgに溶解し、これに調整脂肪(太陽油脂社製)20kgを添加し、均質化し、80℃で6分間殺菌し、濃縮し、噴霧乾燥し、育児用ミルク約100kgを得た。
【0066】
得られた育児用ミルクを前記試験方法により試験した結果、乳化安定性が良好で、風味についても優れた栄養組成物であった。
【0067】
実施例4
7000mlの温水(60℃)に、前記参考例1と同一の方法を反復して得られた乳清蛋白加水分解物2500g、前記参考例3と同一の方法を反復して得られたカゼイン加水分解物2500g、及びデキストリン(参松工業社製)15000gを添加し、TKホモミキサー(特殊機化工業社製)を用いて溶解、分散させ、液状物を調製した。
【0068】
前記液状物に、コハク酸モノグリセリド(花王社製)140g、調整脂肪(太陽油脂社製)2200g、ミネラル混合物(富田製薬社製)400g、及びビタミン混合物(田辺製薬社製)20gを添加し、TKホモミキサー(特殊機化工業社製)を用いて予備乳化し、水を添加して総量を100lに調整した。
【0069】
次いで、予備乳化物を高圧ホモジナイザー(マントンゴーリン株式会社製)を用いて、一段目5MPa、二段目50MPaの2段階処理を5回反復して均質化し、液状流動食約92lを調製した。
【0070】
得られた液状流動食11lを、200mlずつ塩化ビニル樹脂製軟質容器に無菌充填し、のちオートクレーブにより125℃、15分間滅菌し、無菌高カロリー流動食50個を調製した。
【0071】
この無菌高カロリー流動食を前記試験方法により試験した結果、乳化安定性が良好で、風味についても優れた栄養組成物であった。
【0072】
実施例5
市販の脱塩ホエー粉末(蛋白質含量36%。ドモ社製)2kgを5kgの蒸留水に溶解し、乳清蛋白質1kg当たり、蛋白質分解酵素として、パンクレアチン(天野製薬社製)100万活性単位、バシラス・サチリス由来酵素(長瀬生化学工業社製)3万活性単位、及びパパイン(天野製薬社製)10万活性単位を添加し、酵素反応を51℃で5時間実施し、85℃で6分間加熱し、酵素反応を停止し、得られた乳清蛋白加水分解物含有水溶液を真空凍結乾燥機(共和真空社製)を使用し、凍結乾燥し、分解率17%、平均分子量6000ダルトンの乳清蛋白加水分解物約1.9kg(蛋白質680g含有)を製造した。
【0073】
得られた乳清蛋白加水分解物1kg、前記参考例2と同一の方法を反復して得られたカゼイン加水分解物0.65kg、ラクトース(メグレ社製)4.2kg、マルツデキストリン(松谷化学工業社製)4.2kg、ミネラル混合物(富田製薬社製)57g、及びビタミン混合物(田辺製薬社製)2gを精製水20kgに溶解し、これにコハク酸モノグリセリド(花王社製)28g、タピオカ澱粉(松谷化学工業社製)372g及び調整脂肪(太陽油脂社製)2.5kgを添加し、均質化し、120℃で2秒間殺菌し、濃縮し、噴霧乾燥し、育児用ミルク約9kgを得た。
【0074】
得られた育児用ミルクを前記試験方法により試験した結果、乳化安定性が良好で、風味についても優れた栄養組成物であった。
【0075】
【発明の効果】
以上詳記したとおり、本発明は、乳化安定性の良好な流動食、育児用ミルク等の栄養組成物に関するものであり、本発明により奏される効果は次のとおりである。
1)脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物等からなる栄養組成物の乳化安定性を向上させることができる。
2)得られた脂肪、乳清蛋白加水分解物、及びカゼイン加水分解物を主要な成分とする乳化安定性の良好な栄養組成物は、母乳の蛋白質組成に近似しており、アレルゲン性が低減され、乳幼児の保育に有用な育児用ミルク等に応用可能で有用である。[0001]
TECHNICAL FIELD OF THE INVENTION
TECHNICAL FIELD The present invention relates to a nutritional composition such as a liquid food having good emulsion stability and milk for childcare. More specifically, the present invention relates to a nutritional composition having good emulsification stability, which comprises fat, whey protein hydrolyzate, casein hydrolyzate, and succinic monoglyceride and / or tapioca starch as an emulsifier. .
[0002]
In this specification, percentages (%) are values by weight unless otherwise specified.
[0003]
[Prior art]
Conventionally, three kinds of emulsifiers (i) monoglyceride citrate or monoglyceride succinate, (ii) fatty acid monoglyceride, and (iii) lecithin treated with an enzyme are used in combination to thereby improve the stability of emulsified fat and protein hydrolysis. Composition (Japanese Patent No. 2824598; hereinafter, referred to as "prior art 1"), a monoglyceride organic acid ester having an HLB of less than 10, and an acid-resistant salt having an HLB of 10 or more as an emulsifier and an emulsion stabilizer. Nutrient composition composed of fat, protein hydrolyzate, etc., having improved emulsification stability by using a water-soluble surfactant or a salt-resistant polymer compound in combination with them (Japanese Patent Application Laid-Open No. 9-157179. , And Prior Art 2).
[0004]
Further, by using tapioca starch and propylene glycol alginate (hereinafter referred to as PGA) in combination, a stable emulsified food containing no protein hydrolyzate composed of fat or the like having improved emulsification stability (Japanese Patent Application Laid-Open No. No. 23575, hereinafter referred to as prior art 3).
[0005]
However, these conventional techniques have the following disadvantages.
[0006]
[Problems to be solved by the invention]
As disclosed in the above prior art, a nutritional composition comprising a fat, a protein hydrolyzate or the like having improved emulsification stability by using succinic monoglyceride in combination with another emulsifier has been developed. However, in the case of using the whey protein hydrolyzate and the casein hydrolyzate as the protein hydrolyzate in the above-mentioned conventional emulsifier combination, the problem that the emulsification stability of the nutritional composition is insufficient. was there.
[0007]
That is, when three emulsifiers of succinic acid monoglyceride, fatty acid monoglyceride, and enzyme-treated lecithin of the prior art 1 are used in combination, as is clear from the test examples described later, fat, whey protein hydrolyzate, and There was a problem that the emulsion composition of a nutritional composition comprising a casein hydrolyzate or the like had insufficient emulsification stability.
[0008]
In addition, monoglyceride succinate having an HLB of less than 10 as a monoglyceride organic acid ester of the prior art 2 and polyglycerin fatty acid esters such as hexaglycerin monomyristate as an acid- and salt-resistant surfactant having an HLB of 10 or more; When hydroxyethylcellulose and hydroxypropylcellulose are used in combination as the polymer compound, the emulsion stability of a nutritional composition comprising fat, whey protein hydrolyzate, and casein hydrolyzate, as is clear from the test examples described below. Was insufficient.
[0009]
Furthermore, as disclosed in the aforementioned prior art 3, a stable emulsified food containing no protein hydrolyzate composed of fat and the like having improved emulsification stability has been developed by using a combination of tapioca starch and PGA. However, when tapioca starch and PGA are used in combination with an emulsified food containing a protein hydrolyzate, there is a problem that the nutritional composition has insufficient emulsification stability.
[0010]
That is, when tapioca starch and PGA of the above-mentioned prior art 3 were used in combination, emulsification of a nutritional composition comprising fat, whey protein hydrolyzate, casein hydrolyzate, and the like was apparent from the test examples described later. There was a problem that the stability was insufficient.
[0011]
In view of the prior art, the present inventors aimed at improving the emulsification stability of a nutritional composition comprising fat, whey protein hydrolyzate, casein hydrolyzate, and the like. As indicated, various emulsifiers and combinations thereof were tested.
[0012]
As a result, the present inventors have found that when using monoglyceride succinate and / or tapioca starch as an emulsifier, fat, whey protein hydrolyzate And a nutritional composition comprising a casein hydrolyzate and the like were found to be excellent in the emulsification stability, and completed the present invention.
[0013]
An object of the present invention is similar to the protein composition of breast milk, allergenicity is reduced, fats applicable to childcare milk and the like useful for nursing infants, whey protein hydrolyzate, and casein hydrolyzate It is an object of the present invention to provide a novel nutritional composition having excellent emulsification stability and containing as a main component.
[0014]
[Means for Solving the Problems]
The present invention which solves the above-mentioned problems,Good emulsification stability with fat, whey protein hydrolyzate and casein hydrolyzate as main componentsNutrition compositionAnd, Fat, whey protein hydrolyzateas well asCasein hydrolyzateOnly protein sourceGood emulsification stability characterized by containing succinic monoglyceride and / or tapioca starch as emulsifierChildcare milk.
[0015]
Further, the present invention provides the whey protein hydrolyzate, wherein the whey protein hydrolyzate has a protein content of at least 70%, and the following a) to h),
a) The fraction having a molecular weight of 5,000 to 10,000 daltons is less than 1% of the total hydrolyzate,
b) The residual antigen activity measured by the ELISA test using anti-whey protein serum was 10%.-FiveMust be,
c) The ratio of the amount of free amino acids to the total amount of amino acids in the hydrolyzate is 10 to 15%.,
d) The ratio of the amount of free lysine to the amount of total lysine contained in whey protein is 12 to 20%.,
e) The ammonia content is 0.2% or less,
f) a 10% solution in a 1 cm cell having a transmittance measured at 540 nm of 98% or more; g) heating a 5% solution of pH 4-7 at 120 ° C. for 10 minutes without causing precipitation;
h) having antioxidant activity,
Flavorful whey protein hydrolyzate with physicochemical propertiesThe above-mentioned milk for childcare having good emulsion stability.(Hereinafter, described as aspect 1.),Is also a desirable mode.
[0016]
BEST MODE FOR CARRYING OUT THE INVENTION
Next, the present invention will be described in detail.
[0017]
The fat used in the present invention may be any fat as long as it is acceptable for foods or pharmaceuticals.Specifically, soybean oil, corn oil, rapeseed oil, coconut oil, safflower oil, sunflower oil Vegetable oils such as olive oil, lard, tallow, milk fat, animal fats such as fish oil, MCT, highly unsaturated fatty acids (eicosapentaenoic acid, arachidonic acid, docosahexaenoic acid, γ-linolenic acid, dihomo-γ-linolenic acid) Linoleic acid, etc.) and these processing oils and the like can be exemplified. For convenience, commercially available adjusted fats (for example, manufactured by Taiyo Yushi Co., Ltd.) can be used.
[0018]
The whey protein hydrolyzate used in the present invention is a whey protein raw material that is acceptable for foods or pharmaceuticals such as whey, desalted whey, whey protein concentrate (WPC), whey protein isolate (WPI) and the like. Any whey protein hydrolyzate may be used as long as it is hydrolyzed. However, in consideration of the flavor and antigen remaining activity of the whey protein hydrolyzate, the prior application 1 According to the disclosure of Japanese Patent Application Laid-Open No. H08-112063, the hydrolyzate according to Embodiment 1 of the present invention, which is produced by Reference Example 1 described below, is desirable.
[0019]
That is, a hydrolyzate of whey protein having a protein content of at least 70%, the following a) to h),
[0020]
a) The fraction having a molecular weight of 5,000 to 10,000 daltons is less than 1% of the total hydrolyzate
b) The residual antigen activity measured by the ELISA test using anti-whey protein serum was 10%.-5Must be
c) The ratio of the amount of free amino acids to the total amount of amino acids in the hydrolyzate is 10 to 15%.
d) The ratio of the amount of free lysine to the amount of total lysine contained in whey protein is 12 to 20%.
e) The ammonia content is 0.2% or less
f) The transmittance of a 10% solution measured at 540 nm in a 1 cm cell is 98% or more.
g) A 5% solution of pH 4-7 is heated at 120 ° C. for 10 minutes without causing precipitation.
h) having antioxidant activity
It is desirable that the whey protein hydrolyzate has good flavor and physicochemical properties (hereinafter referred to as specific physicochemical properties). In addition, the whey protein hydrolyzate having the above-mentioned specific physicochemical properties and good flavor is poor in emulsification stability as compared with other whey protein hydrolysates. According to the present invention, it has become possible to produce a nutritional composition containing the hydrolyzate of whey protein with good emulsion stability.
[0021]
The casein hydrolyzate used in the present invention is obtained by hydrolyzing a casein protein raw material that is acceptable for food or pharmaceuticals such as casein lactate, acid casein such as casein hydrochloride, casein sodium, casein potassium, and casein salts such as calcium caseinate. Any casein hydrolyzate may be used, and specifically, the prior application 2 (Japanese Unexamined Patent Application Publication No. H8-228692) or the prior application patent 3 (Japanese Unexamined Patent Application Publication No. According to the disclosure of JP-A-28306), the casein hydrolyzate produced in Reference Example 2 or Reference Example 3 described below can be used.
[0022]
The emulsifier used in the present invention must be a food or pharmaceutical acceptable succinic monoglyceride and / or tapioca starch, as is clear from the test examples described below, and these commercial products are succinic monoglycerides (manufactured by Kao Corporation). ), Tapioca starch (Matsuya Chemical Industry Co., Ltd.) and the like can be used. The amount of the emulsifier added is 0.01 to 15% based on the solid content of the nutritional composition. In order to further improve the emulsion stability, it is necessary to use either succinic acid monoglyceride or tapioca starch alone, and it is particularly preferable to use succinic acid monoglyceride alone.
[0023]
As a protein source of the nutritional composition having good emulsification stability of the present invention, whey protein hydrolyzate and casein hydrolyzate, which are main components, are used in an amount of 60% or more of the total protein. , A degradation product thereof, or an amino acid can also be used. As proteins other than whey protein hydrolyzate and casein hydrolyzate, one or a combination of two or more of soy protein, egg protein, fish protein, meat protein, wheat protein, corn protein, lactoferrin, lactoperoxidase, etc. Can be exemplified.
[0024]
The ratio of whey protein hydrolyzate and casein hydrolyzate as protein can be appropriately changed in the range of 1: 9 to 9: 1, but is intended for application to infant care milk useful for nursing infants. The ratio is preferably about 1.5: 1, which is close to the ratio of whey protein and casein protein in breast milk.
[0025]
Fat, whey protein hydrolyzate, casein hydrolyzate, which are the main components of the nutritional composition having good emulsification stability of the present invention, as components other than the emulsifier, carbohydrates that are acceptable in foods or pharmaceuticals, Dietary fiber, nucleic acids, vitamins, minerals and the like can be exemplified.
[0026]
Examples of the saccharide include one or a combination of two or more of dextrin, lactose, sucrose, glucose, fructose, maltose, lactulose, and raffinose.
[0027]
Examples of the dietary fiber include one or a combination of two or more of cellulose, resistant dextrin, and gum arabic.
[0028]
Examples of the nucleic acid include one or a combination of two or more nucleotides, nucleosides, DNA, RNA, bases, and the like.
[0029]
As vitamins, vitamin A, vitamin B1, Vitamin B2  , Vitamin B6  ,vitamin12, Vitamin C, vitamin D3, Vitamin E, vitamin K, niacin, pantothenic acid, folic acid, β-carotene and the like, or a combination of two or more of them. For convenience, a commercially available vitamin mixture (for example, manufactured by Tanabe Seiyaku Co., Ltd.) Etc.) can be used.
[0030]
Examples of the mineral include one or a combination of two or more of salts such as sodium, potassium, chlorine, calcium, magnesium, iron, copper, zinc, and manganese. A mixture (for example, manufactured by Tomita Pharmaceutical Co., Ltd.) can be used.
[0031]
Furthermore, as needed, fruit juice, flavors, lactic acid bacteria powder, bifidobacterium powder, and the like can be used.
[0032]
The mixing ratio of total fat, total protein, and total carbohydrate in the nutritional composition having good emulsion stability of the present invention is mixed at various ratios from a nutritional viewpoint depending on the purpose of use. For example, the mixing ratio of the infant milk is usually about 10 to 30% for fat, about 10 to 20% for protein, and about 50 to 70% for carbohydrate, based on the solid content of the infant milk. The vitamins and minerals, which are trace components, are added in nutritionally necessary amounts as appropriate.
[0033]
The method for preparing the nutritional composition of the present invention can be prepared by a conventional method corresponding to the type of the nutritional composition.In the case of a typical nutritional composition for childcare milk, it is prepared as follows. You.
[0034]
Specifically, the whey protein hydrolyzate, the casein hydrolyzate, the saccharide, the mineral mixture, and the vitamin mixture are dissolved in purified water, and the emulsifier and the fat are added thereto, and the mixture is homogenized. , Sterilized by a conventional method, concentrated, and spray-dried to prepare milk for childcare.
[0035]
The nutritional composition of the present invention obtained as described above, as is clear from the examples and test examples described later, fat, whey protein hydrolyzate, and the emulsion stability of the nutritional composition composed of casein hydrolyzate, etc. Since it is good, it is close to the protein composition of mother's milk, has reduced allergenicity, and is applicable and useful for childcare milk and the like useful for nursing infants.
[0036]
Next, the present invention will be described in detail with reference to test examples. In the present invention, the following test method was adopted.
[0037]
(1) Evaluation method of emulsion stability
The sample was dissolved in distilled water at a solid content of 15%, and 10 ml of the solution was collected in a 50 ml centrifuge tube, centrifuged at 2,000 rpm for 5 minutes, and the volume (ml) of the cream layer floating on the upper layer was measured. It was used as an evaluation index for emulsion stability.
[0038]
Test example 1
This test was performed to show that the nutritional composition of the present invention is superior in the emulsion stability as compared with the nutritional composition manufactured by the prior art.
[0039]
(1) Sample preparation
The following five types of samples were prepared.
Sample 1: Nutritional composition produced by the same method as in Example 1 of the present invention
Sample 2: Nutritional composition manufactured by the same method as in Example 1 of the present invention except that 6 kg of tapioca starch of the present invention was used alone as an emulsifier.
Sample 3: Nutritional composition manufactured by the same method as in Example 1 of the present invention, except that 450 g of succinic monoglyceride, 450 g of fatty acid monoglyceride and 450 g of enzyme-treated lecithin were used in combination as an emulsifier.
Sample 4: manufactured by the same method as in Example 1 of the present invention except that 1440 g of succinic acid monoglyceride, 960 g of hexaglycerin monomyristate, 600 g of hydroxyethylcellulose, and 600 g of hydroxypropylcellulose of the prior art 2 were used as emulsifiers. Nutrition composition
Sample 5: A nutritional composition produced by the same method as in Example 1 of the present invention, except that 6 kg of tapioca starch of prior art 3 and 440 g of PGA were used in combination as emulsifiers.
[0040]
(2) Test method
The emulsification stability of each sample was measured five times for each sample according to the test method described above, and the average value was calculated and tested.
[0041]
(3) Test results
The results of this test are as shown in Table 1. As is clear from Table 1, it was found that Sample 1 of the present invention had a smaller floating amount of the cream layer and was superior in emulsification stability as compared with Samples 2 to 4 using the conventional emulsifier.
[0042]
In addition, although the kind and amount of the fat, whey protein hydrolyzate and casein hydrolyzate of the nutritional composition were changed and tested, almost the same results were obtained.
[0043]
[Table 1]
Figure 0003579617
[0044]
Test example 2
This test was carried out with the emulsification stability as an index to investigate the type and combination of appropriate emulsifiers in a nutritional composition composed of fat, whey protein hydrolyzate, casein hydrolyzate, and the like.
[0045]
(1) Sample preparation
Except that the type of emulsifier and the combination thereof were changed, the following 11 types of samples (sample numbers 6 to 16) were prepared in the same manner as in Example 1.
Sample 6: Nutritional composition produced by the same method as in Example 1 of the present invention
Sample 7: A nutritional composition produced by the same method as in Example 1 of the present invention, except that 6 kg of the tapioca starch of the present invention was used alone as an emulsifier.
Sample 8: A nutritional composition produced by the same method as in Example 1 of the present invention, except that 450 g of the succinic monoglyceride of the present invention and 6 kg of tapioca starch were used in combination as emulsifiers.
Sample 9: Nutritional composition manufactured by the same method as in Example 1 of the present invention except that 450 g of citric acid monoglyceride was used alone as an emulsifier.
[0046]
Sample 10: Nutritional composition manufactured by the same method as in Example 1 of the present invention except that 6 kg of potato starch was used alone as an emulsifier.
Sample 11: Nutritional composition produced by the same method as in Example 1 of the present invention except that 450 g of citric acid monoglyceride and 6 kg of tapioca starch were used in combination as emulsifiers.
Sample 12: A nutritional composition produced by the same method as in Example 1 of the present invention except that 450 g of succinic monoglyceride and 6 kg of potato starch were used in combination as an emulsifier.
Sample 13: A nutritional composition produced by the same method as in Example 1 of the present invention except that 450 g of citrate monoglyceride and 6 kg of potato starch were used in combination as emulsifiers.
Sample 14: Nutritional composition manufactured by the same method as in Example 1 of the present invention, except that 450 g of stearic acid monoglyceride was used alone as an emulsifier.
Sample 15: Nutritional composition manufactured by the same method as Example 1 of the present invention except that 450 g of stearic acid monoglyceride and 6 kg of tapioca starch were used in combination as emulsifiers.
Sample 16: Nutritional composition produced by the same method as in Example 1 of the present invention except that 450 g of stearic acid monoglyceride and 6 kg of potato starch were used in combination as an emulsifier.
[0047]
(2) Test method
The emulsification stability of each sample was measured five times for each sample according to the test method described above, and the average value was calculated and tested.
[0048]
(3) Test results
The results of this test are as shown in Table 2. As is clear from Table 2, in order to improve the emulsification stability of the nutritional composition comprising fat, whey protein hydrolyzate, casein hydrolyzate and the like, succinic monoglyceride and / or tapioca starch are used as emulsifiers. It turned out to be necessary. Further, in order to further improve the emulsion stability, it is necessary to use either succinic acid monoglyceride or tapioca starch alone, and it has been found that it is particularly preferable to use succinic acid monoglyceride alone.
[0049]
In addition, although the kind and amount of the fat, whey protein hydrolyzate and casein hydrolyzate of the nutritional composition were changed and tested, almost the same results were obtained.
[0050]
[Table 2]
Figure 0003579617
[0051]
Reference Example 1
A whey protein hydrolyzate was prepared as follows by the same method as in Example 2 of the prior patent 1 (Japanese Patent Application Laid-Open No. H08-112063).
[0052]
1 kg of a commercially available whey protein powder (protein content: 85%; manufactured by Protein, Denmark) is dissolved in 19 kg of deionized water, the pH is adjusted to 10, and trypsin (manufactured by Novo Nordisk) is added to 110,000 active units. (130 activity units per gram of whey protein), 1.8 million activity units of protease N Amano (manufactured by Amano Pharmaceutical Co., Ltd.) (2100 activity units per gram of whey protein) and 51,000 activity units of disrupted Lactobacillus vulgaricus cells (60 activity units per gram of whey protein), hydrolyze at 40 ° C., and measure the amount of free lysine with time using a Biotech Analyzer (manufactured by Asahi Kasei Kogyo Co., Ltd.). When the temperature reached 130 ° C., the enzyme was inactivated by heating at 130 ° C. for 2 seconds, cooled, then adjusted to pH 6.5 with citric acid, and subjected to ultrafiltration with a cut-off molecular weight of 3,000. (Asahi Kasei Kogyo) in ultrafiltered, concentrated, and spray-dried to obtain a powdery whey protein hydrolyzate to about 800 g.
[0053]
In the obtained whey protein hydrolyzate, a fraction having a molecular weight of 5,000 to 10,000 daltons had 0.2% of the total hydrolyzate and an antigen residual activity of 10%.-6Hereinafter, the release rate of lysine is 17%, the free amino acid content is 13%, the ammonia content is 0.04%, the transmittance of a 10% solution is 99%, the pH of a 5% solution is not adjusted, and 120 ° C. at pH 4 for 10 minutes. Was stable even when heated, had the same antioxidant activity as α-tocopherol, and had a good flavor.
[0054]
Reference Example 2
A casein hydrolyzate was prepared as follows by the same method as in Example 2 of the prior application 2 (Japanese Patent Application Laid-Open No. 8-228692).
[0055]
8.5 kg of distilled water was added to 1.5 kg of commercially available casein (manufactured by Merck), dispersed well, and a 10% aqueous sodium hydroxide solution was added to adjust the pH of the solution to 7.0. After dissolution, a casein aqueous solution having a concentration of about 15% was prepared. The casein aqueous solution is sterilized by heating at 85 ° C. for 10 minutes, the temperature is adjusted to 50 ° C., the pH is adjusted to 9.0 by adding sodium hydroxide, and then bioprase SP-20 (manufactured by Nagase Seikagaku Corporation). 15.12 million activity units (1200 activity units per gram of protein), Neutrase (Novo Nordisk) 6.30 million activity units (5000 activity units per gram of protein), and chymotrypsin (Novo Nordisk) 10.8 million An activity unit (8000 activity units per gram of protein) was added to start a hydrolysis reaction, and the degradation rate of casein and the number of moles of 16 kinds of amino acids measured with a Biotech Analyzer (manufactured by Asahi Kasei Kogyo Co., Ltd.) with time. The total measured value was measured, and the casein decomposition rate was 25.5% and the value measured by the Biotech Analyzer was 7.2. Upon reaching M, enzymes were inactivated by heating for 5 minutes at 85 ° C., the enzymatic reaction was stopped and cooled to 10 ° C.. Activated carbon (60 g) was added to the hydrolyzed solution, and the mixture was stirred and allowed to stand for 20 hours. As a filtration aid, Standard Supercell (manufactured by Tokyo Diatomaceous Earth) was added, and the mixture was suction-filtered. The resulting solution was concentrated and spray-dried to obtain 1.32 kg of a spray-dried product.
[0056]
In the obtained casein hydrolyzate, a fraction having a molecular weight of 500 daltons or less was 60.9%, a fraction having a molecular weight of 500 to 1,000 daltons was 22.9%, a fraction of 1,000 to 5,000 daltons was 16.2%, 0% fraction over 5000 daltons, 10% residual antigen activity-5And the amino acid release rate were 5.9%, and the flavor was good.
[0057]
Reference Example 3
A casein hydrolyzate was prepared as follows by the same method as in Example 2 of the prior application patent 3 (Japanese Patent Application Laid-Open No. 9-28306).
[0058]
9 kg of distilled water was added to 1 kg of commercially available sodium caseinate (protein content: 85%, manufactured by Uniere France) and mixed well with stirring to completely dissolve the sodium caseinate to prepare a casein aqueous solution having a concentration of about 10%. The casein aqueous solution was sterilized by heating at 80 ° C. for 10 minutes, the temperature was adjusted to 50 ° C., the pH was adjusted to 9.0 by adding sodium hydroxide, and 13.6 million activity units of bromelain (manufactured by Amano Pharmaceutical Co., Ltd.) (1 g of protein) 16,000 activity units per 1g), Neutrase (manufactured by Novo Nordisk) 1,770,000 activity units (2000 activity units per gram of protein), and Protease S (manufactured by Amano Pharmaceutical Co., Ltd.) 1,200,000 activity units (1200 activity units per gram of protein) Was added to start the hydrolysis reaction, and the enzymatic reaction was monitored by the degradation rate over time. When the degradation rate reached 25.6%, the enzyme was inactivated by heating at 80 ° C. for 6 minutes, The enzyme reaction was stopped and cooled to 10 ° C. The hydrolyzed solution is filtered by a membrane separation method (microfiltration) using Microza EMP-313 (pore size: 0.25 μm, manufactured by Asahi Kasei Corporation), and the obtained filtrate is subjected to hydrophobic treatment. The filtrate was subjected to SV (space velocity) = 2 h for a hydrophilic resin [KS-35 (manufactured by Hokuetsu Carbon Co., Ltd.)].-1The solution containing the casein hydrolyzate was concentrated by a conventional method and spray-dried to obtain 0.74 kg of a spray-dried product.
[0059]
The obtained casein hydrolyzate contained 82.5% of the fraction having a molecular weight of 1,000 daltons or less, 0.2% of the fraction having a molecular weight of 3500 daltons or more, 5.3% of the amino acid release rate, and tryptophan contained in 1 g. 3.5 mg and the transmittance was 99.4%. Further, the flavor (odor, taste) was almost tasteless and odorless, and was a substance excellent in storage stability (no precipitation, no coloring).
[0060]
Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to the following examples.
[0061]
【Example】
Example 1
15 kg of whey protein hydrolyzate obtained by repeating the same method as in Reference Example 1, 10 kg of casein hydrolyzate obtained by repeating the same method as in Reference Example 2, lactose (manufactured by Megre) 68 kg, 1120 g of raffinose (manufactured by Nippon Beet Sugar Co., Ltd.), 14.6 kg of maltdextrin (manufactured by Matsutani Chemical Industry), 920 g of a mineral mixture (manufactured by Tomita Pharmaceutical Co., Ltd.), and 35 g of a vitamin mixture (manufactured by Tanabe Seiyaku Co., Ltd.) were added to 300 kg of purified water. The mixture was dissolved, and 450 g of succinic monoglyceride (manufactured by Kao Corporation) and 40 kg of adjusted fat (manufactured by Taiyo Yushi Kabushiki Kaisha) were added. The mixture was homogenized, sterilized at 120 ° C. for 2 seconds, concentrated, spray-dried, and dried for childcare milk. 145 kg were obtained.
[0062]
When the obtained milk for childcare was tested by the above-mentioned test method, it was found that the nutritional composition had good emulsification stability and excellent flavor.
[0063]
Example 2
10.8 kg of whey protein hydrolyzate obtained by repeating the same method as in Reference Example 1, 5.6 kg of casein hydrolyzate obtained by repeating the same method as in Reference Example 2, lactulose ( Purify 500 g of Morinaga Milk Industry Co., Ltd., 500 g of raffinose (manufactured by Nippon Sugar Bee Co., Ltd.), 65 kg of maltdextrin (manufactured by Matsutani Chemical Industry Co., Ltd.), 920 g of mineral mixture (manufactured by Tomita Pharmaceutical Co., Ltd.), and 35 g of vitamin mixture (manufactured by Tanabe Seiyaku Co., Ltd.) Dissolve in 300 kg of water, add 500 g of succinic monoglyceride (manufactured by Kao Corporation) and 20 kg of adjusted fat (manufactured by Taiyo Yushi Co., Ltd.), homogenize, sterilize at 80 ° C. for 6 minutes, concentrate, spray dry, and raise About 100 kg of milk for use was obtained.
[0064]
When the obtained milk for childcare was tested by the above-mentioned test method, it was found that the nutritional composition had good emulsification stability and excellent flavor.
[0065]
Example 3
10 kg of whey protein hydrolyzate obtained by repeating the same method as in Reference Example 1, 6 kg of casein hydrolyzate obtained by repeating the same method as in Reference Example 2, lactulose (manufactured by Morinaga Milk Industry Co., Ltd.) ), 500 g of raffinose (manufactured by Nippon Sugar Beet Co., Ltd.), 62 kg of malt dextrin (manufactured by Matsutani Chemical Industry Co., Ltd.), 3 kg of tapioca starch (manufactured by Matsutani Chemical Industry Co., Ltd.), 920 g of a mineral mixture (manufactured by Tomita Pharmaceutical Co., Ltd.), and 920 g of a vitamin mixture (Tanabe Corporation) 35 g of purified water was dissolved in 300 kg of purified water, and 20 kg of adjusted fat (manufactured by Taiyo Yushi Co., Ltd.) was added thereto, homogenized, sterilized at 80 ° C. for 6 minutes, concentrated, spray-dried, and milk for childcare was added. 100 kg were obtained.
[0066]
When the obtained milk for childcare was tested by the above-mentioned test method, it was found that the nutritional composition had good emulsification stability and excellent flavor.
[0067]
Example 4
2500 g of whey protein hydrolyzate obtained by repeating the same method as in Reference Example 1 in 7000 ml of warm water (60 ° C.), and casein hydrolysis obtained by repeating the same method as in Reference Example 3 2,500 g of the product and 15000 g of dextrin (manufactured by Sanmatsu Kogyo) were added and dissolved and dispersed using a TK homomixer (manufactured by Tokushu Kika Kogyo Co., Ltd.) to prepare a liquid.
[0068]
140 g of succinic acid monoglyceride (manufactured by Kao Corporation), 2200 g of adjusted fat (manufactured by Taiyo Yushi Co., Ltd.), 400 g of a mineral mixture (manufactured by Tomita Pharmaceutical Co., Ltd.), and 20 g of a vitamin mixture (manufactured by Tanabe Seiyaku Co., Ltd.) were added to the liquid, and TK was added. Preliminary emulsification was performed using a homomixer (manufactured by Tokushu Kika Kogyo Co., Ltd.), and water was added to adjust the total amount to 100 l.
[0069]
Next, the pre-emulsion was homogenized using a high-pressure homogenizer (manton-Gaulin Co., Ltd.) by repeating the two-stage treatment of 5 MPa in the first stage and 50 MPa in the second stage five times to prepare about 92 l of liquid fluid food.
[0070]
11 l of the obtained liquid liquid food was aseptically filled into 200 ml of a soft container made of a vinyl chloride resin, and then sterilized in an autoclave at 125 ° C. for 15 minutes to prepare 50 sterilized high calorie liquid foods.
[0071]
As a result of testing this sterilized high calorie liquid food by the test method described above, the nutritional composition was found to have good emulsion stability and excellent flavor.
[0072]
Example 5
2 kg of commercially available desalted whey powder (protein content: 36%, manufactured by Domo) is dissolved in 5 kg of distilled water, and 1 kg of whey protein contains 1 million active units of pancreatin (manufactured by Amano Pharmaceutical Co., Ltd.) as a protease. Bacillus subtilis-derived enzyme (manufactured by Nagase Seikagaku Corporation) (30,000 activity units) and papain (Amano Pharmaceutical Co., Ltd.) 100,000 activity units were added, and the enzyme reaction was carried out at 51 ° C for 5 hours and at 85 ° C for 6 minutes. The mixture was heated to stop the enzyme reaction, and the resulting aqueous solution containing whey protein hydrolyzate was freeze-dried using a vacuum freeze dryer (manufactured by Kyowa Vacuum Co., Ltd.) to obtain a milk having a decomposition rate of 17% and an average molecular weight of 6,000 daltons. About 1.9 kg of a protein hydrolyzate (containing 680 g of protein) was produced.
[0073]
1 kg of the obtained whey protein hydrolyzate, 0.65 kg of the casein hydrolyzate obtained by repeating the same method as in Reference Example 2, 4.2 kg of lactose (manufactured by Megre), and maltdextrin (Matsuya Chemical Industries, Ltd.) 4.2 g, a mineral mixture (manufactured by Tomita Pharmaceutical Co., Ltd.) 57 g, and a vitamin mixture (manufactured by Tanabe Seiyaku Co., Ltd.) 2 g were dissolved in purified water 20 kg. 372 g of Matsutani Chemical Industry Co., Ltd. and 2.5 kg of adjusted fat (manufactured by Taiyo Yushi Co., Ltd.) were added, homogenized, sterilized at 120 ° C. for 2 seconds, concentrated, and spray-dried to obtain about 9 kg of milk for childcare.
[0074]
The obtained milk for childcare was tested by the above-mentioned test method. As a result, the nutritional composition was found to have good emulsification stability and excellent flavor.
[0075]
【The invention's effect】
As described above in detail, the present invention relates to a nutritional composition such as a liquid diet and milk for childcare having good emulsion stability. The effects of the present invention are as follows.
1) It is possible to improve the emulsion stability of a nutritional composition comprising a fat, a whey protein hydrolyzate, a casein hydrolyzate, and the like.
2) The nutritional composition with good emulsion stability, which contains the obtained fat, whey protein hydrolyzate and casein hydrolyzate as main components, is similar to the protein composition of breast milk and has reduced allergenicity. It is applicable and useful for childcare milk and the like useful for childcare of infants.

Claims (2)

脂肪、乳清蛋白加水分解物及びカゼイン加水分解物を主要な成分とする乳化安定性の良好な栄養組成物であって、脂肪、乳清蛋白加水分解物及びカゼイン加水分解物のみからなる蛋白質源、及び乳化剤としてコハク酸モノグリセリド及び/又はタピオカ澱粉を含有することを特徴とする乳化安定性の良好な育児用ミルク。 Fat, a good nutritional composition emulsion stability of whey protein hydrolyzate and casein hydrolyzate major component, a protein source comprising fat, whey protein hydrolyzate and casein hydrolyzate only A milk for childcare having good emulsification stability, which contains succinic monoglyceride and / or tapioca starch as an emulsifier . 乳清蛋白加水分解物が、少なくとも70(重量)%の蛋白質を含有する乳清蛋白質の加水分解物であって、次のa)〜h)、
a)分子量5000〜10000ダルトンの画分が、全加水分解物の1(重量)%未満であること
b)抗乳清蛋白質血清を用いたエライザ抑制試験法により測定した抗原残存活性が10-5以下であること
c)加水分解物の全アミノ酸の量に対する遊離アミノ酸の量の割合が10〜15(重量)%であること
d)乳清蛋白質に含まれる全リジンの量に対する遊離リジンの量の割合が12〜20(重量)%であること
e)アンモニア含量が0.2(重量)%以下であること
f)10(重量)%溶液を1cmのセル、540nmで測定した透過率が98%以上であること
g)pH4〜7の5(重量)%溶液を120℃で10分間加熱して沈澱を生じないこと、h)抗酸化活性を有すること
の理化学的性質を有する風味良好な乳清蛋白加水分解物であることを特徴とする請求項1に記載の乳化安定性の良好な育児用ミルク。
The whey protein hydrolyzate is a whey protein hydrolyzate containing at least 70% (by weight) protein, the following a) to h);
a) the fraction having a molecular weight of 5,000 to 10,000 daltons is less than 1% (by weight) of the total hydrolyzate ;
b) the residual antigen activity measured by the ELISA test using anti-whey protein serum is 10 -5 or less ;
c) the ratio of the amount of free amino acids to the total amount of amino acids in the hydrolyzate is 10 to 15 (weight)% ;
d) the ratio of the amount of free lysine to the amount of total lysine contained in whey protein is 12 to 20 (weight)% ,
e) the ammonia content is not more than 0.2 (weight)% ;
f) a 10% (by weight) solution having a transmittance of 98% or more measured at 540 nm in a 1 cm cell ,
g) heating a 5% (by weight) solution of pH 4-7 at 120 ° C. for 10 minutes without precipitation, h) having antioxidant activity ,
The milk of claim 1, wherein the milk is a hydrolyzate of whey protein having good physicochemical properties and good flavor .
JP23140399A 1999-08-18 1999-08-18 Nutritional composition with good emulsion stability Expired - Fee Related JP3579617B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23140399A JP3579617B2 (en) 1999-08-18 1999-08-18 Nutritional composition with good emulsion stability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23140399A JP3579617B2 (en) 1999-08-18 1999-08-18 Nutritional composition with good emulsion stability

Publications (2)

Publication Number Publication Date
JP2001054367A JP2001054367A (en) 2001-02-27
JP3579617B2 true JP3579617B2 (en) 2004-10-20

Family

ID=16923067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23140399A Expired - Fee Related JP3579617B2 (en) 1999-08-18 1999-08-18 Nutritional composition with good emulsion stability

Country Status (1)

Country Link
JP (1) JP3579617B2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4680827B2 (en) * 2006-05-02 2011-05-11 テルモ株式会社 Gel-like nutritional composition containing milk protein
JP5380649B2 (en) * 2007-03-16 2014-01-08 株式会社アップウェル Milk component hydrolyzate
MY158225A (en) * 2007-11-07 2016-09-15 Mjn Us Holdings Llc Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas
JP5179950B2 (en) * 2008-05-26 2013-04-10 雪印メグミルク株式会社 Folic acid and / or vitamin B12-lactoferrin complex
JP5712429B2 (en) * 2008-07-09 2015-05-07 株式会社アップウェル Apolactoferrin-containing composition
JP5673903B1 (en) * 2013-08-28 2015-02-18 不二製油株式会社 Granular vegetable protein material
WO2015029555A1 (en) * 2013-08-28 2015-03-05 不二製油株式会社 Granular vegetable-protein material
JP7190811B2 (en) * 2017-12-28 2022-12-16 アサヒグループ食品株式会社 METHOD FOR MANUFACTURING EMULSION COMPOSITION FOR FOOD AND BEVERAGE AND METHOD FOR SUPPRESSING MEILLARD REACTION OF EMULSION COMPOSITION FOR FOOD AND BEVERAGE
JP7252733B2 (en) * 2018-10-29 2023-04-05 森永乳業株式会社 Method for producing milk protein hydrolyzate
CN117858631A (en) * 2021-12-24 2024-04-09 森永乳业株式会社 Nutritional composition

Also Published As

Publication number Publication date
JP2001054367A (en) 2001-02-27

Similar Documents

Publication Publication Date Title
JP6234227B2 (en) Nutritional composition for improving intestinal flora
JP6158380B2 (en) Nutritional composition good for the small intestine
JP5688818B2 (en) Nutritional composition
WO1996011584A1 (en) Peptide mixture and products thereof
JP2016531114A (en) Nutritional composition that inhibits tumor growth
JP3579617B2 (en) Nutritional composition with good emulsion stability
US20030040475A1 (en) Agents for improving lipid metabolism and reducing high blood pressure
JPWO2008136420A1 (en) Liquid nutritional composition containing whey protein at high concentration and method for producing the same
JP3871821B2 (en) Protein-containing acidic food and drink
JP2014520549A (en) Composition with improved protein digestibility
JP6093300B2 (en) Composition for preventing and / or improving irreversible metabolic disorders associated with cancer
US20210112826A1 (en) Compositions and nutritional products with improved emulsion stability
JP2001097883A (en) Aloe-containing nutritive composition
JP5695326B2 (en) Protein synthesis promoter
JP2959747B2 (en) Savory whey protein hydrolyzate and method for producing the same
JP3789564B2 (en) Preparation method of polyamine
JP3886915B2 (en) Peptide milk
JP4050799B2 (en) Tight junction formation accelerator
JP2009149550A (en) Lipid absorption promoter
JPWO2018221526A1 (en) Nutrition composition
JP2020068668A (en) Milk protein hydrolyzate and method of producing the same
WO2023054594A1 (en) Method for producing peptide
JP4694053B2 (en) Infant nutrition composition
Gonzalez et al. Advances in Milk Fractionation for Value Addition
JPWO2018159659A1 (en) Liquid nutrient composition containing protein derived from fermented milk components

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040415

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040614

TRDD Decision of grant or rejection written
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040614

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040713

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040716

R150 Certificate of patent or registration of utility model

Ref document number: 3579617

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080723

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080723

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090723

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090723

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100723

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110723

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110723

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120723

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120723

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130723

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees